Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Centre Hospitalier Regional Et Universitaire De Brest
Sponsor

Centre Hospitalier Regional Et Universitaire De Brest

France 2 Avenue Marechal Foch, 29200 Brest, France

About the sponsor

Centre Hospitalier Regional Et Universitaire De Brest is involved in research on aortic stenosis, pulmonary embolism, deep vein thrombosis, venous thromboembolism, and pulmonary arterial hypertension. Its studies also address post-procedural cardiac conduction issues and vascular complications linked to thrombotic disease.

  • Transcatheter aortic valve complications
  • Pulmonary vascular remodeling
  • Recurrent venous thrombosis
  • Thrombosis prevention

Additional interests include imaging-based assessment of cardiopulmonary function and the detection of occult malignancy in patients with thromboembolic disease.

About Specializations

Centre Hospitalier Regional Et Universitaire De Brest runs clinical trials in conditions such as Myeloproliferative neoplasm, Pulmonary embolism, Lung neoplasm malignant, Polymyalgia rheumatica, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

17 clinical trials

Lung neoplasm malignant

Recruiting

Comparing Lung Perfusion PET/CT-Guided Versus Standard Planning for Stereotactic Body Radiotherapy in Patients with Primary or Secondary Lung Tumors

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Gallium (68GA)
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Polymyalgia rheumatica

Recruiting

Study of baricitinib versus placebo for treating polymyalgia rheumatica in adult patients

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Study on Botulinum Toxin Type A for Preventing Shoulder Deformity in Infants with Brachial Plexus Palsy

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Sodium Chloride
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Thyroidectomy+1

Recruiting

Study of Indocyanine Green Angiography to Prevent Hypoparathyroidism in Patients Undergoing Total Thyroid Removal

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Indocyanine Green
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Polycythaemia vera+4

Recruiting

Study on Apixaban, Rivaroxaban, and Aspirin for Preventing Blood Clots in Patients with JAK2V617F-Positive Myeloproliferative Neoplasms

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Pulmonary embolism+7

Recruiting

Study on Rosuvastatin for Reducing Blood Clots in Patients with Deep Vein Thrombosis or Pulmonary Embolism

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rosuvastatin Calcium
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Aortic stenosis

Recruiting

Study on Aortic Stenosis: Evaluating Fludeoxyglucose (18F) for Patients with Conduction Disorders After Aortic Valve Procedures

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fludeoxyglucose (18F)
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Cerebral haemorrhage+2

Recruiting

Study on Naloxegol to Prevent Constipation in Patients with Brain Injury and Opioid Use

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Naloxegol Oxalate
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Neuralgia

Recruiting

Study on Capsaicin Patch for Treating Chronic Neuropathic Pain in Children Aged 12-17

Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Capsaicin
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Myeloproliferative neoplasm

Not yet recruiting

Anakinra for patients with myeloproliferative neoplasms resistant to cytoreductive therapy: a study to improve treatment response

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Pulmonary arterial hypertension

Not yet recruiting

Study of gallium-68 FAPI imaging to assess blood vessel changes in patients with pulmonary arterial hypertension receiving sotatercept

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Gallium (68GA)
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Pulmonary embolism

Not yet recruiting

Study on Lung Function After Pulmonary Embolism Using Galligas and 68Ga-MAA in Patients with Pulmonary Embolism

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Graphite
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.